Your browser doesn't support javascript.
loading
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.
Creasy, Caitlin A; Meng, Yuzhong Jeff; Forget, Marie-Andrée; Karpinets, Tatiana; Tomczak, Katarzyna; Stewart, Chip; Torres-Cabala, Carlos A; Pilon-Thomas, Shari; Sarnaik, Amod A; Mulé, James J; Garraway, Levi; Bustos, Matias; Zhang, Jianhua; Patel, Sapna P; Diab, Adi; Glitza, Isabella C; Yee, Cassian; Tawbi, Hussein; Wong, Michael K; McQuade, Jennifer; Hoon, Dave S B; Davies, Michael A; Hwu, Patrick; Amaria, Rodabe N; Haymaker, Cara; Beroukhim, Rameen; Bernatchez, Chantale.
Affiliation
  • Creasy CA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
  • Meng YJ; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Forget MA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Karpinets T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tomczak K; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
  • Stewart C; Department of Genomic Medicine, The University of Texas MDACC, Houston, Texas.
  • Torres-Cabala CA; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, Texas.
  • Pilon-Thomas S; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Sarnaik AA; Department of Pathology, The University of Texas MDACC, Houston, Texas.
  • Mulé JJ; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Garraway L; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Bustos M; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Zhang J; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Patel SP; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Diab A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Glitza IC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Yee C; Department of Translational Molecular Medicine, Saint John's Cancer Institute, Saint John's Health Center, Santa Monica, California.
  • Tawbi H; Department of Genomic Medicine, The University of Texas MDACC, Houston, Texas.
  • Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
  • McQuade J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
  • Hoon DSB; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
  • Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
  • Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
  • Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
  • Haymaker C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
  • Beroukhim R; Department of Translational Molecular Medicine, Saint John's Cancer Institute, Saint John's Health Center, Santa Monica, California.
  • Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
Clin Cancer Res ; 28(9): 1911-1924, 2022 05 02.
Article in En | MEDLINE | ID: mdl-35190823

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms, Second Primary / Melanoma Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms, Second Primary / Melanoma Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: Estados Unidos